Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Short term Debt (2020 - 2025)

Icu Medical's Short term Debt history spans 6 years, with the latest figure at $18.8 million for Q4 2025.

  • For the quarter ending Q4 2025, Short term Debt fell 63.24% year-over-year to $18.8 million, compared with a TTM value of $18.8 million through Dec 2025, down 63.24%, and an annual FY2025 reading of $18.8 million, down 63.24% over the prior year.
  • Short term Debt for Q4 2025 was $18.8 million at Icu Medical, down from $47.8 million in the prior quarter.
  • The five-year high for Short term Debt was $51.0 million in Q4 2023, with the low at $300000.0 in Q3 2022.
  • Average Short term Debt over 5 years is $26.3 million, with a median of $26.3 million recorded in 2021.
  • Year-over-year, Short term Debt tumbled 98.86% in 2022 and then surged 15129.33% in 2023.
  • Tracing ICUI's Short term Debt over 5 years: stood at $26.3 million in 2021, then rose by 12.88% to $29.7 million in 2022, then surged by 71.79% to $51.0 million in 2023, then changed by 0.0% to $51.0 million in 2024, then plummeted by 63.24% to $18.8 million in 2025.
  • Per Business Quant, the three most recent readings for ICUI's Short term Debt are $18.8 million (Q4 2025), $47.8 million (Q1 2025), and $51.0 million (Q4 2024).